Sam-A Pharm. Co., Ltd

₩12,990As of Sun 8 Nov 2026, 12:00 UTC
KOSDAQ:009300Healthcare
Country South Korea
PE (Fwd) •••
TSR 10Y CAGR (2.07%)
Div yield 6.54%
ROE 4.65%
Pharmaceutical Preparations
Beta (5Y) 0.31
PE TTM 7.521
TSR TTM (17.59%)
Mkt cap ₩79.28B
ROIC 4.10%
SE Grade™
Value
Quality
Moat
Consensus
Reference
₩16,193
24.66%
402.65%
Hold 5|5|4|10|5
4Q25
1Q26
2Q26
3Q26
Earnings per share₩
185.99
200.88
198.42
217.72
4.12%
17.57%
7.31%
20.40%
Revenue₩B
5.770
5.791
5.891
6.143
(2.12%)
(2.75%)
(0.10%)
5.24%
Peers (US$58.45M)
Cap (US$)
PE
60.85M
2.961x
57.85M
8.731x
58.02M
13.45x
Capital
TTM
5Y
10Y
Leveragex
0.399
(0.213)
(0.189)
EBIT/Intx
3.144
0.048
0.055
Own earn%
249.00
47.12
31.66
Sh yield%
21.37
51.28
45.48
Owners
Insiders/Inst%
4.16
23.08
Short interest%
1.74
SBC / revenue%
0.89
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
15
Op margin range%
4–11
$1 testx
0.6
Incr. ROIC%
0